DK172587B1 - Fremgangsmåde til bestemmelse af koncentrationen af en analyt, analytisk anordning samt prøvesæt til brug ved fremgangsmåde - Google Patents
Fremgangsmåde til bestemmelse af koncentrationen af en analyt, analytisk anordning samt prøvesæt til brug ved fremgangsmåde Download PDFInfo
- Publication number
- DK172587B1 DK172587B1 DK198801830A DK183088A DK172587B1 DK 172587 B1 DK172587 B1 DK 172587B1 DK 198801830 A DK198801830 A DK 198801830A DK 183088 A DK183088 A DK 183088A DK 172587 B1 DK172587 B1 DK 172587B1
- Authority
- DK
- Denmark
- Prior art keywords
- analyte
- receptor
- binding sites
- labeled
- marker
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 122
- 238000000034 method Methods 0.000 title claims abstract description 55
- 230000008569 process Effects 0.000 title claims description 7
- 238000012360 testing method Methods 0.000 title description 12
- 230000027455 binding Effects 0.000 claims abstract description 48
- 239000003550 marker Substances 0.000 claims abstract description 32
- 238000004448 titration Methods 0.000 claims abstract description 23
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 239000003153 chemical reaction reagent Substances 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 20
- 230000000903 blocking effect Effects 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 9
- 229940088597 hormone Drugs 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 3
- 229910052747 lanthanoid Inorganic materials 0.000 claims description 3
- 150000002602 lanthanoids Chemical class 0.000 claims description 3
- 230000036963 noncompetitive effect Effects 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000036961 partial effect Effects 0.000 claims description 2
- 230000009870 specific binding Effects 0.000 claims description 2
- 102000005962 receptors Human genes 0.000 description 104
- 239000000523 sample Substances 0.000 description 36
- 238000005259 measurement Methods 0.000 description 18
- 238000003018 immunoassay Methods 0.000 description 15
- 238000002372 labelling Methods 0.000 description 15
- 238000003556 assay Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 239000011324 bead Substances 0.000 description 8
- 239000012086 standard solution Substances 0.000 description 7
- 239000004793 Polystyrene Substances 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 238000012937 correction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000011325 microbead Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229910052693 Europium Inorganic materials 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 238000002967 competitive immunoassay Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000007830 receptor-based assay Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 108010032595 Antibody Binding Sites Proteins 0.000 description 1
- 101000800130 Bos taurus Thyroglobulin Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 102000016979 Other receptors Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000003302 anti-idiotype Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- XMLNCADGRIEXPK-KUMOIWDRSA-M chembl2146143 Chemical compound [Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C)C(=O)C(CO)C1=CC=CC=C1 XMLNCADGRIEXPK-KUMOIWDRSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- LNBHUCHAFZUEGJ-UHFFFAOYSA-N europium(3+) Chemical compound [Eu+3] LNBHUCHAFZUEGJ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- PUPFATUGTIQBQA-UZQPLGKSSA-N fluorophen Chemical compound C([C@@]1(C)C2=CC(O)=CC=C2C[C@H]2[C@@H]1C)CN2CCC1=CC=C(F)C=C1 PUPFATUGTIQBQA-UZQPLGKSSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000013391 scatchard analysis Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Spectrometry And Color Measurement (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868619206A GB8619206D0 (en) | 1986-08-06 | 1986-08-06 | Fluorometric determination of analyte concentration |
| GB8619206 | 1986-08-06 | ||
| EP87306995A EP0271974B1 (en) | 1986-08-06 | 1987-08-06 | Determination of analyte concentration using two labelling markers |
| GB8700558 | 1987-08-06 | ||
| EP87306995 | 1987-08-06 | ||
| PCT/GB1987/000558 WO1988001058A1 (en) | 1986-08-06 | 1987-08-06 | Determination of analyte concentration using two labelling markers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK183088D0 DK183088D0 (da) | 1988-04-05 |
| DK183088A DK183088A (da) | 1988-04-05 |
| DK172587B1 true DK172587B1 (da) | 1999-02-08 |
Family
ID=26110703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198801830A DK172587B1 (da) | 1986-08-06 | 1988-04-05 | Fremgangsmåde til bestemmelse af koncentrationen af en analyt, analytisk anordning samt prøvesæt til brug ved fremgangsmåde |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US5171695A (fi) |
| JP (1) | JP2690011B2 (fi) |
| AT (1) | ATE86385T1 (fi) |
| AU (1) | AU614935B2 (fi) |
| DK (1) | DK172587B1 (fi) |
| FI (1) | FI92881C (fi) |
| NO (1) | NO172517C (fi) |
| WO (1) | WO1988001058A1 (fi) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599720A (en) * | 1982-08-27 | 1997-02-04 | Multilyte Limited | Measurement of analyte concentration |
| GB8803000D0 (en) * | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
| US5807755A (en) * | 1987-08-06 | 1998-09-15 | Multilyte Limited | Determination of ambient concentrations of several analytes |
| US6551784B2 (en) | 1989-06-07 | 2003-04-22 | Affymetrix Inc | Method of comparing nucleic acid sequences |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US6379895B1 (en) | 1989-06-07 | 2002-04-30 | Affymetrix, Inc. | Photolithographic and other means for manufacturing arrays |
| CA2021658C (en) * | 1989-08-25 | 2001-10-09 | Myron J. Block | Multiplex immunoassay system |
| US6008057A (en) * | 1989-08-25 | 1999-12-28 | Roche Diagnostics Corporation | Immunoassay system |
| US5252743A (en) * | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
| EP0515370B1 (en) * | 1990-02-22 | 1995-03-01 | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING (McGILL UNIVERSITY) | A solid-phase interferometric immunoassay system |
| JP3097866B2 (ja) * | 1991-10-15 | 2000-10-10 | マルティライト リミティド | 標識試薬を使用した結合検定法 |
| US6943034B1 (en) | 1991-11-22 | 2005-09-13 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
| US5960344A (en) * | 1993-12-20 | 1999-09-28 | Norand Corporation | Local area network having multiple channel wireless access |
| GB9326451D0 (en) * | 1993-12-24 | 1994-02-23 | Multilyte Ltd | Binding assay |
| GB9326450D0 (en) * | 1993-12-24 | 1994-02-23 | Multilyte Ltd | Binding assay |
| US7625697B2 (en) | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
| US5751629A (en) | 1995-04-25 | 1998-05-12 | Irori | Remotely programmable matrices with memories |
| US6331273B1 (en) | 1995-04-25 | 2001-12-18 | Discovery Partners International | Remotely programmable matrices with memories |
| US6329139B1 (en) | 1995-04-25 | 2001-12-11 | Discovery Partners International | Automated sorting system for matrices with memory |
| US6017496A (en) | 1995-06-07 | 2000-01-25 | Irori | Matrices with memories and uses thereof |
| US5874214A (en) | 1995-04-25 | 1999-02-23 | Irori | Remotely programmable matrices with memories |
| US6416714B1 (en) | 1995-04-25 | 2002-07-09 | Discovery Partners International, Inc. | Remotely programmable matrices with memories |
| US5679309A (en) * | 1995-12-14 | 1997-10-21 | Beckman Instruments, Inc. | Automated random access analyzer |
| US6709869B2 (en) | 1995-12-18 | 2004-03-23 | Tecan Trading Ag | Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system |
| US5874216A (en) * | 1996-02-23 | 1999-02-23 | Ensys Environmental Products, Inc. | Indirect label assay device for detecting small molecules and method of use thereof |
| WO1997032212A1 (en) * | 1996-03-01 | 1997-09-04 | Beckman Instruments, Inc. | System for simultaneously conducting multiple ligand binding assays |
| DE59607877D1 (de) * | 1996-03-13 | 2001-11-15 | Hoffmann La Roche | Optochemisches Verfahren und Messanordnung zur Messung der Konzentration eines Analyten |
| US6143248A (en) * | 1996-08-12 | 2000-11-07 | Gamera Bioscience Corp. | Capillary microvalve |
| WO1998028623A1 (en) | 1996-12-20 | 1998-07-02 | Gamera Bioscience Corporation | An affinity binding-based system for detecting particulates in a fluid |
| US6632399B1 (en) | 1998-05-22 | 2003-10-14 | Tecan Trading Ag | Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system for performing biological fluid assays |
| US6063589A (en) | 1997-05-23 | 2000-05-16 | Gamera Bioscience Corporation | Devices and methods for using centripetal acceleration to drive fluid movement on a microfluidics system |
| AU9020698A (en) | 1997-08-15 | 1999-03-08 | Alexion Pharmaceuticals, Inc. | Apparatus for performing assays at reaction sites |
| US7157234B2 (en) | 1997-10-24 | 2007-01-02 | Beckman Coulter, Inc. | Detection of very low quantities of analyte bound to a solid phase |
| GB9808836D0 (en) | 1998-04-27 | 1998-06-24 | Amersham Pharm Biotech Uk Ltd | Microfabricated apparatus for cell based assays |
| GB9809943D0 (en) * | 1998-05-08 | 1998-07-08 | Amersham Pharm Biotech Ab | Microfluidic device |
| ATE272213T1 (de) * | 1999-06-18 | 2004-08-15 | Gamera Bioscience Corp | Vorrichtungen und verfahren zur durchführung miniaturisierter homogener tests |
| US6645733B1 (en) * | 1999-06-25 | 2003-11-11 | Ingeneus Corporation | Fluorescent intensity method for assaying binding between proteins or peptides |
| US6267884B1 (en) * | 2000-01-04 | 2001-07-31 | Waters Investments Limited | Capillary columns employing monodispersed particles |
| AU2001292959A1 (en) | 2000-09-22 | 2002-04-02 | Clontech Laboratories, Inc. | Highly sensitive proteomic analysis methods and kits and systems for practicing the same |
| AU2002235170A1 (en) * | 2000-11-07 | 2002-05-21 | James O. Bowlby Jr. | Method in quantitative analysis of gene and protein expression |
| JP3856214B2 (ja) * | 2002-03-11 | 2006-12-13 | 横河電機株式会社 | 蛍光強度増強ビーズ |
| US20050079507A1 (en) * | 2003-10-09 | 2005-04-14 | Ye Fang | Target evaluation using biological membrane arrays |
| GB0421838D0 (en) | 2004-09-30 | 2004-11-03 | Congenia S R L | Cancer markers |
| US20060263265A1 (en) * | 2005-05-23 | 2006-11-23 | Der-Ren Kang | Blood micro-separator |
| US20070111326A1 (en) * | 2005-11-14 | 2007-05-17 | Abbott Laboratories | Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia |
| WO2008008284A2 (en) | 2006-07-14 | 2008-01-17 | The Regents Of The University Of California | Cancer biomarkers and methods of use threof |
| US20120003639A1 (en) | 2010-04-27 | 2012-01-05 | Prelude, Inc. | Cancer biomarkers and methods of use thereof |
| GB201016403D0 (en) | 2010-09-29 | 2010-11-10 | Bath Ventures | Novel interaction between staphylococcus aureus Sbi and C3d protiens |
| WO2016090323A1 (en) | 2014-12-05 | 2016-06-09 | Prelude, Inc. | Dcis recurrence and invasive breast cancer |
| WO2018148489A1 (en) * | 2017-02-09 | 2018-08-16 | Promega Corporation | Analyte detection immunoassay |
| JP2022500504A (ja) | 2018-09-14 | 2022-01-04 | プレリュード コーポレーションPrelude Corporation | 浸潤性乳癌のリスクを有する対象の治療の選択方法 |
| GB2602268B (en) * | 2020-12-18 | 2022-12-14 | Forsite Diagnostics Ltd | Time-resolved fluorescence reader and method |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4341957A (en) * | 1975-11-26 | 1982-07-27 | Analytical Radiation Corporation | Fluorescent antibody composition for immunofluorometric assay |
| CA1111762A (en) * | 1977-12-28 | 1981-11-03 | David S. Frank | Fluorescent rare earth chelate in polymeric latex particles |
| US4381291A (en) * | 1979-02-23 | 1983-04-26 | Ab Fortia | Measurement of free ligands |
| GB2057685B (en) * | 1979-03-19 | 1983-12-21 | Int Diagnostic Tech | Double tagged immunoassay |
| JPS5651665A (en) * | 1979-09-24 | 1981-05-09 | Radiochemical Centre Ltd | Method of analysing isolated part of matter in biological fluid |
| US4366143A (en) * | 1979-09-24 | 1982-12-28 | Amersham International Public Limited Company | Assay for the free portion of substances in biological fluids |
| WO1984001031A1 (en) * | 1982-08-27 | 1984-03-15 | Roger Philip Ekins | Measurement of analyte concentration |
-
1987
- 1987-08-06 AU AU77559/87A patent/AU614935B2/en not_active Expired
- 1987-08-06 JP JP62504712A patent/JP2690011B2/ja not_active Expired - Lifetime
- 1987-08-06 US US07/317,471 patent/US5171695A/en not_active Expired - Lifetime
- 1987-08-06 AT AT87306995T patent/ATE86385T1/de not_active IP Right Cessation
- 1987-08-06 WO PCT/GB1987/000558 patent/WO1988001058A1/en active IP Right Grant
-
1988
- 1988-03-21 NO NO881241A patent/NO172517C/no not_active IP Right Cessation
- 1988-04-05 DK DK198801830A patent/DK172587B1/da not_active IP Right Cessation
-
1989
- 1989-02-03 FI FI890526A patent/FI92881C/fi not_active IP Right Cessation
-
1992
- 1992-09-18 US US07/947,149 patent/US20020160524A1/en not_active Abandoned
-
2002
- 2002-06-18 US US10/174,904 patent/US20030082832A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU7755987A (en) | 1988-02-24 |
| AU614935B2 (en) | 1991-09-19 |
| WO1988001058A1 (en) | 1988-02-11 |
| NO172517C (no) | 1993-07-28 |
| FI890526A0 (fi) | 1989-02-03 |
| FI92881C (fi) | 1995-01-10 |
| US5171695A (en) | 1992-12-15 |
| JPH01503405A (ja) | 1989-11-16 |
| US20020160524A1 (en) | 2002-10-31 |
| JP2690011B2 (ja) | 1997-12-10 |
| NO881241D0 (no) | 1988-03-21 |
| NO881241L (no) | 1988-03-21 |
| US20030082832A1 (en) | 2003-05-01 |
| FI92881B (fi) | 1994-09-30 |
| ATE86385T1 (de) | 1993-03-15 |
| NO172517B (no) | 1993-04-19 |
| DK183088D0 (da) | 1988-04-05 |
| FI890526A (fi) | 1989-02-03 |
| DK183088A (da) | 1988-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK172587B1 (da) | Fremgangsmåde til bestemmelse af koncentrationen af en analyt, analytisk anordning samt prøvesæt til brug ved fremgangsmåde | |
| CA1113841A (en) | Test device and method for its use | |
| CN1759319B (zh) | 生物液中肾上腺髓质素原中间区域部分肽在制备免疫诊断剂中的用途 | |
| FI92110C (fi) | Useiden analyyttien vallitsevien konsentraatioiden määrittäminen | |
| JP4619372B2 (ja) | 改良された対照区画を有する免疫学的試験素子 | |
| DK156925B (da) | Analytisk multilagsmateriale, dets fremstilling og anvendelse | |
| EP0070300A1 (en) | SOLID PHASE SYSTEM FOR TEST WITH BINDING AGENT. | |
| DK172582B1 (da) | Fremgangsmåde og testkit til bestemmelse af koncentrationen af en i en biologisk væske tilstedeværende aktiv forbindelse | |
| EP0141298A1 (en) | Analytical method and element for albumin | |
| JPH0750114B2 (ja) | 免疫分析器具を用いる分析方法 | |
| US20180074074A1 (en) | Homogenous and heterogeneous assays and systems for determination of ocular biomarkers | |
| US4786606A (en) | Solid phase system for ligand assay | |
| Gutierrez et al. | Immunoassay methods based on fluorescence polarization | |
| US20040161857A1 (en) | Test strip for chromatography and process for producing the same | |
| EP0271974B1 (en) | Determination of analyte concentration using two labelling markers | |
| US4032626A (en) | Reagent and method for tbg assay | |
| US4307071A (en) | Analytical reagent and method | |
| EP1716420A1 (en) | Method for a rapid test | |
| RU2480772C1 (ru) | Способ одновременного детектирования тиротропина и общего тироксина в сухих пятнах крови | |
| EP0596074A1 (en) | Improved wash technique for immunoassay | |
| Arakawa et al. | Fluorescent enzyme immunoassay of free thyroxin using glucose oxidase as enzyme label | |
| Keller et al. | in [nsect tsio [ogy | |
| JPH01257262A (ja) | 均質なｔ−４取込み分析法 | |
| Simple et al. | PROCEEDINGS OF CSCC CONVENTION | |
| Ratcliffe | Methods of Analysis of Thyroid-Related Hormones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |